
Scott Long
Examiner (ID: 10754, Phone: (571)272-9048 , Office: P/1633 )
| Most Active Art Unit | 1633 |
| Art Unit(s) | 1633 |
| Total Applications | 882 |
| Issued Applications | 557 |
| Pending Applications | 29 |
| Abandoned Applications | 301 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5337860
[patent_doc_number] => 20090054324
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-26
[patent_title] => 'Transcriptional Regulation of High Affitnity Ige Receptor Gamma-Chain'
[patent_app_type] => utility
[patent_app_number] => 11/992239
[patent_app_country] => US
[patent_app_date] => 2006-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4692
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20090054324.pdf
[firstpage_image] =>[orig_patent_app_number] => 11992239
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/992239 | Transcriptional regulation of high affinity IgE receptor γ-chain | Sep 19, 2006 | Issued |
Array
(
[id] => 4905820
[patent_doc_number] => 20080115234
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-15
[patent_title] => 'Method for utilization of domestic ruminants with mycobacterium avium subspecies paratuberculosis disease to assess possible therapeutic modalities'
[patent_app_type] => utility
[patent_app_number] => 11/521200
[patent_app_country] => US
[patent_app_date] => 2006-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1529
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0115/20080115234.pdf
[firstpage_image] =>[orig_patent_app_number] => 11521200
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/521200 | Method for utilization of domestic ruminants with mycobacterium avium subspecies paratuberculosis disease to assess possible therapeutic modalities | Sep 13, 2006 | Abandoned |
Array
(
[id] => 5056902
[patent_doc_number] => 20070059824
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-15
[patent_title] => 'Human umbilical cord blood-derived pluripotent fibroblast-like-macrophages'
[patent_app_type] => utility
[patent_app_number] => 11/519307
[patent_app_country] => US
[patent_app_date] => 2006-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10728
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20070059824.pdf
[firstpage_image] =>[orig_patent_app_number] => 11519307
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/519307 | Human umbilical cord blood-derived pluripotent fibroblast-like-macrophages | Sep 11, 2006 | Abandoned |
Array
(
[id] => 5131143
[patent_doc_number] => 20070207540
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-06
[patent_title] => 'Method of producing three-dimensional tissue and method of producing extracellular matrix used in the same'
[patent_app_type] => utility
[patent_app_number] => 11/514468
[patent_app_country] => US
[patent_app_date] => 2006-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 10235
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0207/20070207540.pdf
[firstpage_image] =>[orig_patent_app_number] => 11514468
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/514468 | Method of producing three-dimensional tissue and method of producing extracellular matrix used in the same | Aug 31, 2006 | Issued |
Array
(
[id] => 4771369
[patent_doc_number] => 20080057027
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-06
[patent_title] => 'METHODS AND DEVICES TO REGULATE STEM CELL HOMING'
[patent_app_type] => utility
[patent_app_number] => 11/469092
[patent_app_country] => US
[patent_app_date] => 2006-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 16510
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0057/20080057027.pdf
[firstpage_image] =>[orig_patent_app_number] => 11469092
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/469092 | Methods and devices to regulate stem cell homing | Aug 30, 2006 | Issued |
Array
(
[id] => 5690122
[patent_doc_number] => 20060288437
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-21
[patent_title] => 'Zinc finger-based drug-dependent gene regulation system'
[patent_app_type] => utility
[patent_app_number] => 11/506567
[patent_app_country] => US
[patent_app_date] => 2006-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 13610
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0288/20060288437.pdf
[firstpage_image] =>[orig_patent_app_number] => 11506567
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/506567 | Zinc finger-based drug-dependent gene regulation system | Aug 17, 2006 | Abandoned |
Array
(
[id] => 8102943
[patent_doc_number] => 08153117
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-04-10
[patent_title] => 'Chondrocyte therapeutic delivery system'
[patent_app_type] => utility
[patent_app_number] => 11/463714
[patent_app_country] => US
[patent_app_date] => 2006-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 12569
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/153/08153117.pdf
[firstpage_image] =>[orig_patent_app_number] => 11463714
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/463714 | Chondrocyte therapeutic delivery system | Aug 9, 2006 | Issued |
Array
(
[id] => 6501162
[patent_doc_number] => 20100215720
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-26
[patent_title] => 'IMPLANTABLE OPTICAL SYSTEM, METHOD FOR DEVELOPING IT AND APPLICATIONS'
[patent_app_type] => utility
[patent_app_number] => 12/376603
[patent_app_country] => US
[patent_app_date] => 2006-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5893
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0215/20100215720.pdf
[firstpage_image] =>[orig_patent_app_number] => 12376603
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/376603 | IMPLANTABLE OPTICAL SYSTEM, METHOD FOR DEVELOPING IT AND APPLICATIONS | Aug 7, 2006 | Abandoned |
Array
(
[id] => 4502682
[patent_doc_number] => 07919672
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-04-05
[patent_title] => 'Suppression of B-cell apoptosis in transgenic animals expressing humanized immunoglobulin'
[patent_app_type] => utility
[patent_app_number] => 11/498571
[patent_app_country] => US
[patent_app_date] => 2006-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 11
[patent_no_of_words] => 13734
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/919/07919672.pdf
[firstpage_image] =>[orig_patent_app_number] => 11498571
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/498571 | Suppression of B-cell apoptosis in transgenic animals expressing humanized immunoglobulin | Aug 1, 2006 | Issued |
Array
(
[id] => 4820341
[patent_doc_number] => 20080226612
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-18
[patent_title] => 'Compositions of Cells Enriched for Combinations of Various Stem and Progenitor Cell Populations, Methods of Use Thereof and Methods of Private Banking Thereof'
[patent_app_type] => utility
[patent_app_number] => 12/064034
[patent_app_country] => US
[patent_app_date] => 2006-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3707
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0226/20080226612.pdf
[firstpage_image] =>[orig_patent_app_number] => 12064034
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/064034 | Compositions of Cells Enriched for Combinations of Various Stem and Progenitor Cell Populations, Methods of Use Thereof and Methods of Private Banking Thereof | Aug 1, 2006 | Abandoned |
Array
(
[id] => 4824988
[patent_doc_number] => 20080124344
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-29
[patent_title] => 'Novel Gene Disruptions, Compositions and Methods Relating Thereto'
[patent_app_type] => utility
[patent_app_number] => 11/814549
[patent_app_country] => US
[patent_app_date] => 2006-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 111
[patent_figures_cnt] => 111
[patent_no_of_words] => 216686
[patent_no_of_claims] => 141
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0124/20080124344.pdf
[firstpage_image] =>[orig_patent_app_number] => 11814549
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/814549 | Gene disruptions, compositions and methods relating thereto | Jul 17, 2006 | Issued |
Array
(
[id] => 5144114
[patent_doc_number] => 20070006330
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-04
[patent_title] => 'Model for immunocomparability'
[patent_app_type] => utility
[patent_app_number] => 11/474864
[patent_app_country] => US
[patent_app_date] => 2006-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 8860
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0006/20070006330.pdf
[firstpage_image] =>[orig_patent_app_number] => 11474864
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/474864 | Model for immunocomparability | Jun 25, 2006 | Abandoned |
Array
(
[id] => 5580960
[patent_doc_number] => 20090176306
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-09
[patent_title] => 'METHOD OF INDUCING DIFFERENTIATION FROM VISCERAL PREADIPOCYTE TO VISCERAL ADIPOCYTE'
[patent_app_type] => utility
[patent_app_number] => 11/916701
[patent_app_country] => US
[patent_app_date] => 2006-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 3377
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20090176306.pdf
[firstpage_image] =>[orig_patent_app_number] => 11916701
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/916701 | METHOD OF INDUCING DIFFERENTIATION FROM VISCERAL PREADIPOCYTE TO VISCERAL ADIPOCYTE | Jun 11, 2006 | Abandoned |
Array
(
[id] => 5058976
[patent_doc_number] => 20070061898
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-15
[patent_title] => 'Transgenic mouse expressing a polynucleotide encoding human tissue factor'
[patent_app_type] => utility
[patent_app_number] => 11/445777
[patent_app_country] => US
[patent_app_date] => 2006-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 10401
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0061/20070061898.pdf
[firstpage_image] =>[orig_patent_app_number] => 11445777
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/445777 | Transgenic mouse expressing a polynucleotide encoding human tissue factor | Jun 1, 2006 | Abandoned |
Array
(
[id] => 4959666
[patent_doc_number] => 20080274091
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-06
[patent_title] => 'Autologous T Cell Manufacturing Processes'
[patent_app_type] => utility
[patent_app_number] => 10/587437
[patent_app_country] => US
[patent_app_date] => 2006-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 41
[patent_figures_cnt] => 41
[patent_no_of_words] => 28220
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0274/20080274091.pdf
[firstpage_image] =>[orig_patent_app_number] => 10587437
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/587437 | Autologous T Cell Manufacturing Processes | May 21, 2006 | Abandoned |
Array
(
[id] => 4859023
[patent_doc_number] => 20080267873
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-30
[patent_title] => 'Injection Solution for Rna'
[patent_app_type] => utility
[patent_app_number] => 11/914945
[patent_app_country] => US
[patent_app_date] => 2006-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 16388
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0267/20080267873.pdf
[firstpage_image] =>[orig_patent_app_number] => 11914945
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/914945 | Injection Solution for Rna | May 18, 2006 | Abandoned |
Array
(
[id] => 5376146
[patent_doc_number] => 20090313707
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-17
[patent_title] => 'Novel Gene Disruptions, Compositions and Methods Relating Thereto'
[patent_app_type] => utility
[patent_app_number] => 11/814361
[patent_app_country] => US
[patent_app_date] => 2006-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 156
[patent_figures_cnt] => 156
[patent_no_of_words] => 272526
[patent_no_of_claims] => 141
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0313/20090313707.pdf
[firstpage_image] =>[orig_patent_app_number] => 11814361
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/814361 | Gene disruptions, compositions and methods relating thereto | May 17, 2006 | Issued |
Array
(
[id] => 5732252
[patent_doc_number] => 20060257369
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-16
[patent_title] => 'Therapeutic regimen for treating cancer'
[patent_app_type] => utility
[patent_app_number] => 11/432943
[patent_app_country] => US
[patent_app_date] => 2006-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 24307
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0257/20060257369.pdf
[firstpage_image] =>[orig_patent_app_number] => 11432943
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/432943 | Therapeutic regimen for treating cancer | May 11, 2006 | Abandoned |
Array
(
[id] => 84265
[patent_doc_number] => 07741529
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2010-06-22
[patent_title] => 'Transgenic animal model for catecholaminergic polymorphic ventricular tachycardia (CPVT) and use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/429167
[patent_app_country] => US
[patent_app_date] => 2006-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 9240
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/741/07741529.pdf
[firstpage_image] =>[orig_patent_app_number] => 11429167
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/429167 | Transgenic animal model for catecholaminergic polymorphic ventricular tachycardia (CPVT) and use thereof | May 3, 2006 | Issued |
Array
(
[id] => 5732792
[patent_doc_number] => 20060257909
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-16
[patent_title] => 'Methods for reducing the percentage of abnormal gametes'
[patent_app_type] => utility
[patent_app_number] => 11/413123
[patent_app_country] => US
[patent_app_date] => 2006-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7315
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0257/20060257909.pdf
[firstpage_image] =>[orig_patent_app_number] => 11413123
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/413123 | Methods for reducing the percentage of abnormal gametes | Apr 27, 2006 | Abandoned |